📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vericel

1.1 - Company Overview

Vericel Logo

Vericel

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapies for cartilage repair and burn care, including MACI for knee cartilage defects using the patient’s own cultured cells on a collagen membrane; Epicel, a permanent skin replacement for patients with deep dermal or full-thickness burns covering a large percentage of their body; and NexoBrid, a bromelain-based enzymatic solution for eschar removal in adults with deep partial- and/or full-thickness thermal burns.

Products and services

  • Epicel: Delivers permanent skin replacement for patients with deep dermal or full thickness burns covering a large percentage of their body
  • MACI: Creates autologous knee cartilage repair by using the patient's own cultured cells on a collagen membrane to treat cartilage defects in the knee
  • NexoBrid: Offers eschar removal in adults with deep partial- and/or full-thickness thermal burns by utilizing a bromelain-based enzymatic solution

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vericel

CytoSolv Logo

CytoSolv

HQ: United States Website
  • Description: Provider of wound care technology focused on the treatment of diabetic ulcers and other wounds, developing solutions aimed at curing diabetic ulcers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytoSolv company profile →
HemoGenyx Pharmaceuticals Logo

HemoGenyx Pharmaceuticals

HQ: United Kingdom Website
  • Description: Provider of cell-based and antibody immunotherapies for blood diseases. Offerings include HEMO-CAR-T, a modified T-cell therapy for Acute Myeloid Leukemia (AML); CDX, a bispecific monoclonal antibody for relapsed/refractory AML and conditioning for bone marrow transplantation; and CBR, an immunotherapy platform to prevent and combat viral infections and certain cancers, with proof of concept for SARS-COV-2.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HemoGenyx Pharmaceuticals company profile →
International Stem Cell Logo

International Stem Cell

HQ: United States Website
  • Description: Provider of parthenogenesis-based stem cell technologies, including ISC-hpNSC neural stem cells for Parkinson’s disease; Lifeline Cell Technology human cell culture products; Lifeline Skin Care cosmetics using pluripotent stem cell extracts; ChondroStem cartilage regeneration using 3D bioprinting for osteoarthritis; CytoHep hepatocyte-like cells for liver diseases; and Parkinson’s clinical trials in Australia via Cyto Therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full International Stem Cell company profile →
CellTran Logo

CellTran

HQ: United Kingdom Website
  • Description: Provider of biotechnology-based cell therapy and wound management products, focused on research and development for tissue regeneration and wound healing. Offers Myskin for difficult-to-heal wounds, Lyphoderm, a hydrophilic gel from freeze-dried lysate of cultured human keratinocytes, and Ulcodress.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CellTran company profile →
OvaScience Logo

OvaScience

HQ: United States Website
  • Description: Provider of life sciences solutions focused on the discovery, development and commercialization of treatments for infertility.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OvaScience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vericel

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vericel

2.2 - Growth funds investing in similar companies to Vericel

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vericel

4.2 - Public trading comparable groups for Vericel

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vericel

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vericel

What does Vericel do?

Vericel is a provider of therapies for cartilage repair and burn care, including MACI for knee cartilage defects using the patient’s own cultured cells on a collagen membrane; Epicel, a permanent skin replacement for patients with deep dermal or full-thickness burns covering a large percentage of their body; and NexoBrid, a bromelain-based enzymatic solution for eschar removal in adults with deep partial- and/or full-thickness thermal burns.

Who are Vericel's competitors?

Vericel's competitors and similar companies include CytoSolv, HemoGenyx Pharmaceuticals, International Stem Cell, CellTran, and OvaScience.

Where is Vericel headquartered?

Vericel is headquartered in United States.

How many employees does Vericel have?

Vericel has 1,000 employees 🔒.

When was Vericel founded?

Vericel was founded in 2010 🔒.

What sector and industry vertical is Vericel in?

Vericel is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vericel

Who are the top strategic acquirers in Vericel's sector and industry

Top strategic M&A buyers and acquirers in Vericel's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vericel?

Top strategic M&A buyers groups and sectors for Vericel include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vericel's sector and industry vertical

Which are the top PE firms investing in Vericel's sector and industry vertical?

Top PE firms investing in Vericel's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vericel's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vericel's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vericel's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vericel include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vericel's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vericel?

The key public trading comparables and valuation benchmarks for Vericel include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vericel for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vericel with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vericel's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vericel with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vericel's' sector and industry vertical?

Access recent funding rounds and capital raises in Vericel's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vericel